dc.contributor.author | Kielaitė-Gulla, Aistė | |
dc.contributor.author | Denkovskij, Jaroslav | |
dc.contributor.author | Novikova, Jekaterina | |
dc.contributor.author | Misiūnas, Audrius | |
dc.contributor.author | Vitkus, Dalius | |
dc.contributor.author | Račkauskas, Rokas | |
dc.contributor.author | Sokolovas, Vitalijus | |
dc.contributor.author | Strupas, Kęstutis | |
dc.contributor.author | Žiogas, Algirdas | |
dc.date.accessioned | 2023-09-18T16:08:11Z | |
dc.date.available | 2023-09-18T16:08:11Z | |
dc.date.issued | 2021 | |
dc.identifier.issn | 0934-0874 | |
dc.identifier.other | (WOS_ID)000689725500537 | |
dc.identifier.uri | https://etalpykla.vilniustech.lt/handle/123456789/111599 | |
dc.description.abstract | Background and Aims: Primary hepatocytes are considered the gold standard human liver cell model; although availability of human liver tissue remains a challenge and difficulties in isolating viable cells potentially limits their use. Three-dimensional (3D) liver tissues reconstituted from liver cells, termed liver organoids, have enormous potential for investigating aspects of liver disorders. The aim of our study was by integration of multiple novel techniques, including state-of-the-art laparoscopic liver resection, engineering of growth factors or morphogens bound to extracellular matrix, direct cell reprogramming to produce functional 3D liver organoids. | eng |
dc.format | PDF | |
dc.format.extent | p. 204-205 | |
dc.format.medium | tekstas / txt | |
dc.language.iso | eng | |
dc.relation.isreferencedby | Science Citation Index Expanded (Web of Science) | |
dc.source.uri | https://onlinelibrary.wiley.com/doi/10.1111/tri.13944 | |
dc.title | Establishing an in vitro 3D model of functional human liver organoids | |
dc.type | Konferencijos pranešimo santrauka tarptautinėse DB / Conference presentation abstract in an international DB | |
dcterms.references | 0 | |
dc.type.pubtype | T1 - Konferencijos pranešimo tezės tarptautinėse DB / Conference presentation abstract in an international DB | |
dc.contributor.institution | Vilniaus universitetas Vilniaus universiteto ligoninė Santaros klinikos | |
dc.contributor.institution | Valstybinis mokslinių tyrimų institutas Inovatyvios medicinos centras | |
dc.contributor.institution | Valstybinis mokslinių tyrimų institutas Inovatyvios medicinos centras Vilniaus Gedimino technikos universitetas | |
dc.contributor.institution | Valstybinis mokslinių tyrimų institutas Fizinių ir technologijos mokslų centras | |
dc.contributor.institution | Vilniaus universitetas | |
dc.contributor.faculty | Fundamentinių mokslų fakultetas / Faculty of Fundamental Sciences | |
dc.subject.researchfield | M 001 - Medicina / Medicine | |
dc.subject.researchfield | T 005 - Chemijos inžinerija / Chemical engineering | |
dc.subject.researchfield | N 010 - Biologija / Biology | |
dc.subject.vgtuprioritizedfields | FM0202 - Ląstelių ir jų biologiškai aktyvių komponentų tyrimai / Investigations on cells and their biologically active components | |
dc.subject.ltspecializations | L105 - Sveikatos technologijos ir biotechnologijos / Health technologies and biotechnologies | |
dcterms.sourcetitle | Transplant international | |
dc.description.volume | vol. 34 | |
dc.publisher.name | Wiley | |
dc.publisher.city | New York | |
dc.identifier.doi | 000689725500537 | |
dc.identifier.elaba | 104988686 | |